Bicycle Therapeutics Plc

Ownership Transactions Reported by 25 Insiders

Symbol
BCYC on Nasdaq
Location
Blocks A & B, Portway Building, Granta Park, Great Abington, Cambridge, United Kingdom

Insiders trading volume in the past year

Bicycle Therapeutics Plc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Baker Bros. Advisors Lp Director, 10%+ Owner $536M +$21.2M +4.13% Jan 2, 2025
Kate Bingham Director $32.7M Jul 13, 2021
Gregory Paul Winter Director $4.64M Jan 2, 2025
Kevin Lee CHIEF EXECUTIVE OFFICER, Director $4M -$303K -7.04% Oct 2, 2025
Nicholas Keen Chief Scientific Officer $1.36M Jul 3, 2024
Michael Skynner Chief Technology Officer $995K -$103K -9.35% Oct 2, 2025
Santiago Arroyo Chief Development Officer $973K -$69.6K -6.68% Jan 2, 2025
Alistair Milnes Chief Operating Officer $785K -$128K -14% Oct 2, 2025
Nigel Crockett Chief Business Officer $753K -$50.2K -6.25% Jan 2, 2025
Pierre Legault Director $690K Jan 2, 2025
Dominic Smethurst Chief Medical Officer $642K Jan 3, 2023
Jose-Carlos Gutierrez-Ramos Director $571K Jan 2, 2025
Janice Bourque Director $571K Jan 2, 2025
Richard N. Kender Director $571K Jan 2, 2025
Lee Kalowski President and CFO $530K Apr 3, 2023
Michael Charles Ferguson Hannay Chief Prod & Supply Chain Off $447K -$47K -9.53% Oct 2, 2025
Stephen H. Sands Director $432K Jan 2, 2025
Alethia Young Chief Financial Officer $385K -$26.9K -6.54% Oct 2, 2025
Veronica GH Jordan Director $293K Jan 2, 2024
Travis Thompson Chief Accounting Officer $262K -$74.7K -22.2% Oct 2, 2025
Alessandro Riva Director $188K Mar 25, 2025
Robert Charles Swanton Director $132K -$872 -0.65% Oct 2, 2025
Herve Hoppenot Director $108K Sep 8, 2025
Roger Dansey Director $108K Sep 8, 2025
Eric Westin Chief Medical Officer $34.6K Mar 25, 2025

Recent Insider Transactions by Companies or Individuals for Bicycle Therapeutics Plc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.